EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations
Open Access
- 1 August 2005
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 18 (8), 1027-1033
- https://doi.org/10.1038/modpathol.3800438
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Chromogenic In Situ Hybridization for the Detection of HER-2/neuGene Amplification in Breast Cancer With an Emphasis on Tumors With Borderline and Low-Level AmplificationAmerican Journal of Clinical Pathology, 2005
- Prognostic Relevance of Gene Amplifications and Coamplifications in Breast CancerCancer Research, 2004
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Heregulin Regulation of Akt/Protein Kinase B in Breast Cancer CellsBiochemical and Biophysical Research Communications, 1999
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Genistein, a Tyrosine Kinase Inhibitor, Reduces EGF-Induced EGF Receptor Internalization and Degradation in Human Hepatoma HepG2 CellsBiochemical and Biophysical Research Communications, 1996
- Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transductionNature, 1995
- Epidermal growth factor receptors in breast cancer: Association with early relapse and death, poor response to hormones and interactions with neuJournal of Steroid Biochemistry, 1989